Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 2
2011 4
2012 3
2013 5
2014 5
2015 7
2016 8
2017 8
2018 4
2019 8
2020 9
2021 17
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A; LiverScreen Consortium Investigators. Ginès P, et al. Among authors: augustin s. Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10. Hepatology. 2022. PMID: 34537988 Review.
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J. Villanueva C, et al. Among authors: augustin s. Lancet. 2019 Apr 20;393(10181):1597-1608. doi: 10.1016/S0140-6736(18)31875-0. Epub 2019 Mar 22. Lancet. 2019. PMID: 30910320 Clinical Trial.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, Stefanescu H, Ma MM, Mandorfer M, Mergeay-Fabre M, Procopet B, Schwabl P, Ferlitsch A, Semmler G, Berzigotti A, Tsochatzis E, Bureau C, Reiberger T, Bosch J, Abraldes JG, Genescà J. Pons M, et al. Among authors: augustin s. Am J Gastroenterol. 2021 Apr;116(4):723-732. doi: 10.14309/ajg.0000000000000994. Am J Gastroenterol. 2021. PMID: 33982942
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease.
Olveira A, Augustin S, Benlloch S, Ampuero J, Suárez-Pérez JA, Armesto S, Vilarrasa E, Belinchón-Romero I, Herranz P, Crespo J, Guimerá F, Gómez-Labrador L, Martín V, Carrascosa JM. Olveira A, et al. Among authors: augustin s. Life (Basel). 2023 Feb 2;13(2):419. doi: 10.3390/life13020419. Life (Basel). 2023. PMID: 36836776 Free PMC article. Review.
Non-alcoholic fatty liver disease: A poorly known pandemic.
Augustin S, Graupera I, Caballeria J; en nombre del grupo de trabajo sobre «Hígado graso no alcohólico» de la Societat Catalana de Digestologia. Augustin S, et al. Med Clin (Barc). 2017 Dec 20;149(12):542-548. doi: 10.1016/j.medcli.2017.06.026. Epub 2017 Jul 24. Med Clin (Barc). 2017. PMID: 28751080 Review. English, Spanish.
Diagnostic and prognostic markers in liver cirrhosis.
Augustin S, Genescà J. Augustin S, et al. Dis Markers. 2011;31(3):119-20. doi: 10.3233/DMA-2011-0833. Dis Markers. 2011. PMID: 22045396 Free PMC article. No abstract available.
Overall clinical and economic impact of non-alcoholic fatty liver disease.
Sicras-Mainar A, Aller R, Crespo J, Calleja JL, Turnes J, Romero Gómez M, Augustín S. Sicras-Mainar A, et al. Among authors: augustin s. Rev Esp Enferm Dig. 2021 Jun;113(6):396-403. doi: 10.17235/reed.2020.7238/2020. Rev Esp Enferm Dig. 2021. PMID: 33222473 Free article. Review.
84 results